Key result
Implantation of a continuous-flow left ventricular assist device in a patient with a subcutaneous ICD resulted in 31 inappropriate shocks due to electromagnetic interference and oversensing.
Case Report (n=1)
No
Answers are grounded in this paper and cite their sources.
LVAD implantation in a patient with an S-ICD can cause severe electromagnetic interference and inappropriate shocks, highlighting the need to deactivate antitachycardia therapy before surgery and carefully evaluate sensing vectors postoperatively.
HomeCirculation: Arrhythmia and ElectrophysiologyVol. 9, No. 11Subcutaneous Implantable Cardioverter-Defibrillator Shocks After Left Ventricular Assist Device Implantation Free AccessResearch ArticlePDF/EPUBAboutView PDFView EPUBSections ToolsAdd to favoritesDownload citationsTrack citationsPermissions ShareShare onFacebookTwitterLinked InMendeleyReddit Jump toFree AccessResearch ArticlePDF/EPUBSubcutaneous Implantable Cardioverter-Defibrillator Shocks After Left Ventricular Assist Device Implantation Tobias J. Pfeffer, MD, Thorben König, MD, David Duncker, MD, Roman Michalski, MD, Stephan Hohmann, MD, Hanno Oswald, MD, Jan D. Schmitto, MD and Christian Veltmann, MD Tobias J. PfefferTobias J. Pfeffer From the Department of Cardiology and Angiology (T.J.P., T.K., D.D., R.M., S.H., H.O., C.V.) and Department of Cardiac, Thoracic, Transplantation and Vascular Surgery (J.D.S.), Hannover Medical School, Germany. , Thorben KönigThorben König From the Department of Cardiology and Angiology (T.J.P., T.K., D.D., R.M., S.H., H.O., C.V.) and Department of Cardiac, Thoracic, Transplantation and Vascular Surgery (J.D.S.), Hannover Medical School, Germany. , David DunckerDavid Duncker From the Department of Cardiology and Angiology (T.J.P., T.K., D.D., R.M., S.H., H.O., C.V.) and Department of Cardiac, Thoracic, Transplantation and Vascular Surgery (J.D.S.), Hannover Medical School, Germany. , Roman MichalskiRoman Michalski From the Department of Cardiology and Angiology (T.J.P., T.K., D.D., R.M., S.H., H.O., C.V.) and Department of Cardiac, Thoracic, Transplantation and Vascular Surgery (J.D.S.), Hannover Medical School, Germany. , Stephan HohmannStephan Hohmann From the Department of Cardiology and Angiology (T.J.P., T.K., D.D., R.M., S.H., H.O., C.V.) and Department of Cardiac, Thoracic, Transplantation and Vascular Surgery (J.D.S.), Hannover Medical School, Germany. , Hanno OswaldHanno Oswald From the Department of Cardiology and Angiology (T.J.P., T.K., D.D., R.M., S.H., H.O., C.V.) and Department of Cardiac, Thoracic, Transplantation and Vascular Surgery (J.D.S.), Hannover Medical School, Germany. , Jan D. SchmittoJan D. Schmitto From the Department of Cardiology and Angiology (T.J.P., T.K., D.D., R.M., S.H., H.O., C.V.) and Department of Cardiac, Thoracic, Transplantation and Vascular Surgery (J.D.S.), Hannover Medical School, Germany. and Christian VeltmannChristian Veltmann From the Department of Cardiology and Angiology (T.J.P., T.K., D.D., R.M., S.H., H.O., C.V.) and Department of Cardiac, Thoracic, Transplantation and Vascular Surgery (J.D.S.), Hannover Medical School, Germany. Originally published28 Oct 2016https://doi.org/10.1161/CIRCEP.116.004633Circulation: Arrhythmia and Electrophysiology. 2016;9:e004633Case ReportA 42-year-old man experiencing nonischemic cardiomyopathy with severely reduced left ventricular function and advanced heart failure met the criteria for primary prophylactic implantation of an implantable cardioverter-defibrillator (ICD). A subcutaneous ICD (S-ICD; EMBLEM; Boston Scientific, Marlborough, MA) was implanted at a secondary center in November 2015 with the lead (3401; Boston Scientific) tunnelled in left parasternal position. Before implantation, surface ECG screening was performed following the manufacturer's instructions.A few weeks later, the patient was transferred to Hannover Medical School because of heart failure deterioration (New York Heart Association class IV). After careful evaluation, a continuous-flow left ventricular assist device (LVAD; HeartMate 3; Thoratec, Pleasanton, CA) was implanted using conventional sternotomy.1 Approximately 1 hour after LVAD implantation, the patient received 31 S-ICD shocks. The device was immediately deactivated. Interrogation of the S-ICD revealed normal sinus rhythm during the shocks. However, R waves were diminished and superimposed by electric noise caused by the LVAD. Oversensing of electromagnetic interference led to all S-ICD shocks (Figure 1). Manually, all 3 sensing vectors, primary, secondary, and alternate at all available gain settings, were tested for adequate R wave sensing. In not a single configuration, the S-ICD was able to differentiate between R wave and T wave. Even flutter waves (F waves) were discriminated as R waves by the S-ICD (Figure 2). Thus, after LVAD implantation, S-ICD therapy was not feasible any more.Download figureDownload PowerPointFigure 1. Subcutaneous implantable cardioverter-defibrillator (ICD) ECG with primary sensing vector showing inappropriate ICD shock because of oversensing of electric noise caused by the left ventricular assist device.Download figureDownload PowerPointFigure 2. Subcutaneous implantable cardioverter-defibrillator (ICD) ECG with alternate sensing vector showing oversensing of flutter waves and T waves. In this vector, no electromagnetic interference could be observed.Surface ECG screening was repeated after LVAD implantation. Both left and right parasternal electrode placement showed low R wave amplitudes and confirmed the inability of the S-ICD to differentiate between F, R, and T wave (Figure 3).Download figureDownload PowerPointFigure 3. Screening ECG after left ventricular assist device implantation. The ECG showed atrial flutter with low voltage of the R waves. Lead I indicates the alternate sensing vector, lead II the secondary sensing vector, and lead III the primary sensing vector. (paper speed 25 mm/s).After completion of rehabilitation period, the S-ICD was explanted and a conventional transvenous single-chamber ICD was implanted. During a follow-up of 6 months, the ICD showed a regular device function. Up to now, no oversensing or inappropriate therapy occurred.DiscussionThis case report illustrates inappropriate S-ICD shocks because of changes in R wave morphology and amplitude after LVAD implantation. Changes in ECG morphology after LVAD implantation have been described previously.2 However, these consequences need special consideration when surface ECG–based systems like the S-ICD are used.There are only few case reports dealing with the combination of S-ICD and LVAD therapy. One case describes successful combination of an LVAD (HeartMate II; Thoratec) and an S-ICD (SQ-RX pulse generator model 1010; Boston Scientific) without any electromagnetic interference.3Saeed et al4 reported a case in which electromagnetic interference between the S-ICD and the LVAD (HVAD; HeartWare International, Inc, Framingham, MA) was observed. Two out of 3 sensing vectors showed electromagnetic interference after LVAD implantation. The electromagnetic noise was correctly classified by the S-ICD and did not lead to inappropriate shocks.To our knowledge, this report describes the first case with inappropriate S-ICD shocks after LVAD implantation. The S-ICD shocks were caused by electromagnetic interference, changes in R wave morphology, and a decreased R wave amplitude after LVAD implantation.Low voltage of R wave is commonly observed after LVAD implantation.2 Because the device automatically adjusts its sensing threshold to the amplitude of the last sensed events, postoperative low voltage increases the risk of ventricular oversensing.ConclusionsOn the basis of our experience, we recommend deactivation of the antitachycardia therapy of the S-ICD before LVAD implantation. After recovery from surgery and before reactivation of the device, all sensing vectors should be evaluated with respect to adequate sensing and differentiation of R wave and T wave.Because of sparse and inconsistent data about the combination of S-ICDs and LVADs, we recommend to avoid this combination until data have become more conclusive. If a combination of S-ICD and LVAD cannot be avoided, postoperative follow-up should be performed with great caution and under close surveillance, as proposed above.DisclosuresD. Duncker has received a fellowship grant and travel support from Boston Scientific. C. Veltmann has received honoraria for speeches and presentations from Boston Scientific. The other authors report no conflicts.FootnotesCorrespondence to Christian Veltmann, MD, Medizinische Hochschule Hannover, Klinik für Kardiologie und Angiologie, Carl-Neuberg-Str.1, 30625 Hannover, Germany. E-mail [email protected]References1. Schmitto JD, Hanke JS, Rojas SV, Avsar M, Haverich A. First implantation in man of a new magnetically levitated left ventricular assist device (HeartMate III).J Heart Lung Transplant. 2015; 34:858–860. doi: 10.1016/j.healun.2015.03.001.CrossrefMedlineGoogle Scholar2. Martinez SC, Fansler D, Lau J, Novak EL, Joseph SM, Kleiger RE. Characteristics of the electrocardiogram in patients with continuous-flow left ventricular assist devices.Ann Noninvasive Electrocardiol. 2015; 20:62–68. doi: 10.1111/anec.12181.CrossrefMedlineGoogle Scholar3. Raman AS, Shabari FR, Kar B, Loyalka P, Hariharan R. No electromagnetic interference occurred in a patient with a HeartMate II left ventricular assist system and a subcutaneous implantable cardioverter-defibrillator.Tex Heart Inst J. 2016; 43:183–185. doi: 10.14503/THIJ-14-4795.CrossrefMedlineGoogle Scholar4. Saeed D, Albert A, Westenfeld R, Maxhera B, Gramsch-Zabel H, O'Connor S, Lichtenberg A, Winter J. Left ventricular assist device in a patient with a concomitant subcutaneous implantable cardioverter defibrillator.Circ Arrhythm Electrophysiol. 2013; 6:e32–e33. doi: 10.1161/CIRCEP.113.000240.LinkGoogle Scholar Previous Back to top Next FiguresReferencesRelatedDetailsCited By Gordon J, Maynes E, O'Malley T, Pavri B and Tchantchaleishvili V (2021) Electromagnetic interference between implantable cardiac devices and continuous-flow left ventricular assist devices: a review, Journal of Interventional Cardiac Electrophysiology, 10.1007/s10840-020-00930-8, 61:1, (1-10), Online publication date: 1-Jun-2021. Zormpas C, Eiringhaus J, Hillmann H, Hohmann S, Müller-Leisse J, Schmitto J, Veltmann C and Duncker D (2020) Eligibility for subcutaneous implantable cardioverter-defibrillator in patients with left ventricular assist device, Journal of Interventional Cardiac Electrophysiology, 10.1007/s10840-020-00810-1, 60:2, (303-311), Online publication date: 1-Mar-2021. Jin C, Hsu J, Frenkel D, Jacobson J, Iwai S and Ferrick A (2021) Unique technique to relieve left ventricular assist device electromagnetic interference with an implantable cardioverter defibrillator, Journal of Cardiovascular Electrophysiology, 10.1111/jce.14840, 32:2, (551-553), Online publication date: 1-Feb-2021. Braun O (2021) Management of Implantable Cardioverter Defibrillators in Patients with a Left Ventricular Assist Device Case-Based Device Therapy for Heart Failure, 10.1007/978-3-030-70038-6_15, (255-264), . Zormpas C, Eiringhaus J, Hillmann H, Hohmann S, Müller‐Leisse J, Schmitto J, Veltmann C and Duncker D (2020) A novel screening tool to unmask potential interference between S‐ICD and left ventricular assist device, Journal of Cardiovascular Electrophysiology, 10.1111/jce.14769, 31:12, (3286-3292), Online publication date: 1-Dec-2020. Reichert W, Tomaiko E, Kalya A, Kusne S, Lockhart C and Su W (2020) De novo subcutaneous implantable cardioverter-defibrillator in patient with left ventricular assist device, HeartRhythm Case Reports, 10.1016/j.hrcr.2020.07.020, 6:10, (774-776), Online publication date: 1-Oct-2020. Black-Maier E, Lewis R, Barnett A, Pokorney S, Sun A, Koontz J, Daubert J and Piccini J (2020) Subcutaneous implantable cardioverter-defibrillator troubleshooting in patients with a left ventricular assist device: A case series and systematic review, Heart Rhythm, 10.1016/j.hrthm.2020.04.019, 17:9, (1536-1544), Online publication date: 1-Sep-2020. Gordon J, Maynes E, Choi J, Wood C, Weber M, Morris R, Massey H and Tchantchaleishvili V (2020) Ventricular arrhythmias following continuous‐flow left ventricular assist device implantation: A systematic review, Artificial Organs, 10.1111/aor.13665, 44:8, Online publication date: 1-Aug-2020. Ishida Y, Payne J, Field M and Gold M (2020) Electromagnetic interference from left ventricular assist devices in patients with subcutaneous implantable cardioverter‐defibrillators, Journal of Cardiovascular Electrophysiology, 10.1111/jce.14431, 31:5, (1195-1201), Online publication date: 1-May-2020. Gomes J (2020) Ventricular Tachycardia Associated with Left Ventricular Assist Device Heart Rhythm Disorders, 10.1007/978-3-030-45066-3_15, (221-228), . Ellenbogen K, Kalahasty G and Leffler J (2020) Subcutaneous Implantable Cardioverter Defibrillator Therapy with a Left Ventricular Assist Device Cardiac Electrophysiology, 10.1007/978-3-030-28533-3_147, (607-610), . Boulet J, Massie E, Mondésert B, Lamarche Y, Carrier M and Ducharme A (2019) Current Review of Implantable Cardioverter Defibrillator Use in Patients With Left Ventricular Assist Device, Current Heart Failure Reports, 10.1007/s11897-019-00449-8, 16:6, (229-239), Online publication date: 1-Dec-2019. López-Gil M, Fontenla A, Delgado J, Rodríguez-Muñoz D, Papageorgiou N, Iliodromitis K, D'Amario D, Vamvakidou A and Camm C (2019) Subcutaneous implantable cardioverter defibrillators in patients with left ventricular assist devices: case report and comprehensive review, European Heart Journal - Case Reports, 10.1093/ehjcr/ytz057, 3:2, Online publication date: 1-Jun-2019. Johnson V, Hamm C and Schmitt J (2019) Device-Device-InteraktionDevice-device interaction, Herzschrittmachertherapie + Elektrophysiologie, 10.1007/s00399-019-0617-z, 30:2, (183-190), Online publication date: 1-Jun-2019. Gopinathannair R, Cornwell W, Dukes J, Ellis C, Hickey K, Joglar J, Pagani F, Roukoz H, Slaughter M and Patton K (2019) Device Therapy and Arrhythmia Management in Left Ventricular Assist Device Recipients: A Scientific Statement From the American Heart Association, Circulation, 139:20, (e967-e989), Online publication date: 14-May-2019. Karnik A, Helm R and Monahan K (2019) Mechanisms and management of inappropriate therapy in subcutaneous implantable cardioverter defibrillators, Journal of Cardiovascular Electrophysiology, 10.1111/jce.13831, 30:3, (402-409), Online publication date: 1-Mar-2019. Zormpas C, Mueller-Leisse J, Koenig T, Schmitto J, Veltmann C and Duncker D (2019) Electrocardiographic changes after implantation of a left ventricular assist device – Potential implications for subcutaneous defibrillator therapy, Journal of Electrocardiology, 10.1016/j.jelectrocard.2018.11.002, 52, (29-34), Online publication date: 1-Jan-2019. Gabriels J, Donnelly J, Willner J, Beldner S, Patel A, Lima B and Epstein L (2018) Subcutaneous defibrillator lead management in a patient undergoing a sternotomy, Pacing and Clinical Electrophysiology, 10.1111/pace.13457, 41:12, (1681-1683), Online publication date: 1-Dec-2018. Afzal M, Ahmed A, Prutkin J, Saba S, Cha Y, Friedman P, Knight B, Kanwar M, Lampert B and Weiss R (2018) Multicenter Experience of Concomitant Use of Left Ventricular Assist Devices and Subcutaneous Implantable Cardioverter-Defibrillators, JACC: Clinical Electrophysiology, 10.1016/j.jacep.2018.05.002, 4:9, (1261-1262), Online publication date: 1-Sep-2018. Ho G, Braun O, Adler E, Feld G, Pretorius V and Birgersdotter-Green U (2018) Management of Arrhythmias and Cardiac Implantable Electronic Devices in Patients With Left Ventricular Assist Devices, JACC: Clinical Electrophysiology, 10.1016/j.jacep.2018.04.014, 4:7, (847-859), Online publication date: 1-Jul-2018. Parikh V, Sauer A, Friedman P and Sheldon S (2018) Management of cardiac implantable electronic devices in the presence of left ventricular assist devices, Heart Rhythm, 10.1016/j.hrthm.2018.01.017, 15:7, (1089-1096), Online publication date: 1-Jul-2018. Migliore F, Cavalli G, Bottio T, De Franceschi P, Bertaglia E, Gerosa G and Iliceto S (2018) Subcutaneous implantable cardioverter defibrillator in patients awaiting cardiac transplantation or left ventricular assist device for refractory heart failure: a feasible alternative to transvenous device?, ESC Heart Failure, 10.1002/ehf2.12255, 5:3, (218-221), Online publication date: 1-Jun-2018. Saini H, Saini A, Leffler J, Eddy S and Ellenbogen K (2018) Subcutaneous implantable cardioverter defibrillator (S-ICD) shocks in a patient with a left ventricular assist device, Pacing and Clinical Electrophysiology, 10.1111/pace.13273, 41:3, (309-311), Online publication date: 1-Mar-2018. Ahmed A, Patel P, Bagga S, Gilge J, Schleeter T, Lakhani B, Ravichandran A, Donnelley S, Allavatam V, Prystowsky E and Padanilam B (2018) Troubleshooting electromagnetic interference in a patient with centrifugal flow left ventricular assist device and subcutaneous implantable cardioverter defibrillator, Journal of Cardiovascular Electrophysiology, 10.1111/jce.13433, 29:3, (477-481), Online publication date: 1-Mar-2018. Weinstock J and Madias C (2017) The Subcutaneous Defibrillator, Cardiac Electrophysiology Clinics, 10.1016/j.ccep.2017.08.007, 9:4, (775-783), Online publication date: 1-Dec-2017. Raffa G, Morsolini M, Gentile G, Coppola G and Sciacca S (2017) Should subcutaneous implantable cardioverter-defibrillators be implanted in patients who are candidates for continuous flow left ventricular assist device?, European Journal of Internal Medicine, 10.1016/j.ejim.2017.05.004, 43, (e30-e32), Online publication date: 1-Sep-2017. November 2016Vol 9, Issue 11 Advertisement Article InformationMetrics © 2016 American Heart Association, Inc.https://doi.org/10.1161/CIRCEP.116.004633PMID: 27793958 Manuscript receivedAugust 30, 2016Manuscript acceptedSeptember 9, 2016Originally publishedOctober 28, 2016 Keywordsdefibrillators, implantableheart-assist deviceheart failurenoiseshockcardiomyopathiesPDF download Advertisement SubjectsCatheter Ablation and Implantable Cardioverter-DefibrillatorSudden Cardiac Death
No takes yet. Share an insight, caveat, or question.
Pfeffer et al. (2016) conducted a case report in Nonischemic cardiomyopathy and advanced heart failure (n=1). Left ventricular assist device (LVAD) implantation was evaluated on Inappropriate S-ICD shocks. Implantation of a continuous-flow left ventricular assist device in a patient with a subcutaneous ICD resulted in 31 inappropriate shocks due to electromagnetic interference and oversensing.
Synapse has enriched 10 related papers. Consider them for comparative context: